WELCOME TO SALDA

The Southern African Laboratory Diagnostics Association is a body that represents laboratory medicine in Southern Africa and is a unified voice around IVD’s and a collaboration of multinational and local companies who distribute,supply and manufacture In Vitro Diagnostic tests. IVDs contribute to more than 70% of all medical diagnosis and can be used to decrease overall healthcare costs. We believe that broader access to innovative diagnostic tools will drive and support the healthcare paradigm. Our association aims to lead and highlight the relevance and impact of IVD, influence patient lives and wellbeing, improve access, and  propel the market within Southern Africa. We actively engage with necessary stakeholders, public, private, advocacy, patient groups about the value industry brings to patients.

Latest Industry News

27FEB

Near point-of-care tests, tongue swabs, and sputum pooling for TB


To support countries in their efforts to strengthen detection of tuberculosis (TB) disease and drug resistance, WHO issues evidence-based policy guidance on TB testing that is routinely updated.
09JAN

UWC Scientists Develop Low-Cost Rapid Test To Detect Cancer, TB And Long COVID


Scientists at the University of the Western Cape (UWC) have developed a low-cost, highly sensitive and rapid screening test that could significantly improve the early detection of cancer, tuberculosis, and long COVID-19 - all considered as major public health challenges in South Africa.
[READ MORE]
01DEC

Long-Term HIV Control: Could this Combination Therapy Be the Key?


A new study from UC San Francisco shows it may be possible to control HIV without long-term antiviral treatment — an advance that points the way toward a possible cure for a disease that affects 40 million people around the world.
[READ MORE]
09JAN

UWC Scientists Develop Low-Cost Rapid Test To Detect Cancer, TB And Long COVID


Scientists at the University of the Western Cape (UWC) have developed a low-cost, highly sensitive and rapid screening test that could significantly improve the early detection of cancer, tuberculosis, and long COVID-19 - all considered as major public health challenges in South Africa.